A nationwide team led by researchers at Baylor College of Medicine, Texas Children's Hospital and UPMC Children's Hospital of Pittsburgh has proposed a major revision to how Langerhans cell ...

It targets quickly dividing red blood cells to slow their production. A long-acting version, called peginterferon alfa (Pegasys), has fewer side effects. Ropeginterferon alfa-2b-njft (Besremi ...

Rubius Therapeutics is biologically engineering red blood cells to provide ... However, current CAR T cell treatments have shown limited efficacy with severe side effects and overall limited ...

In mammals the heart is a double pump. The right side pumps deoxygenated blood to the lungs and the left side pumps oxygenated blood to the rest of the body tissues. This means that a red blood ...